Liver Fibrosis
164
25
26
77
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
15 trials with published results (9%)
Research Maturity
77 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
7 terminated out of 164 trials
91.7%
+5.2% vs benchmark
11%
18 trials in Phase 3/4
19%
15 of 77 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 77 completed trials
Clinical Trials (164)
Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)
Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes
Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver Fibrosis
Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation
Incidence of Liver Disease-Related Outcomes in People With HIV
City-Hospital Collaboration for Early Detection of Liver Fibrosis in Primary Care: A Secondary Prevention Project in the Grenoble Health Area
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis
The Phase Ⅰd Clinical Trial of Hydronidone Capsules
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial